Immunobiology and treatment of cutaneous T-cell lymphoma

被引:0
|
作者
Goel, Rishi R. [1 ,2 ]
Rook, Alain H. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA
[2] Univ Penn, Inst Immunol & Immune Hlth I3H, Perelman Sch Med, Philadelphia, PA USA
关键词
Cutaneous T cell lymphoma; CTCL; mycosis fungoides; Sezary syndrome; cutaneous oncology; immunotherapy; CHIMERIC ANTIGEN RECEPTOR; FIBROBLAST ACTIVATION PROTEIN; TUMOR BLOOD-VESSELS; ANTITUMOR-ACTIVITY; CHECKPOINT BLOCKADE; PHASE-I; ALPHA-V-BETA-3; INTEGRIN; STROMAL FIBROBLASTS; MONOCLONAL-ANTIBODY; ESTABLISHED TUMORS;
D O I
10.1080/1744666X.2024.2326035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IntroductionPrimary cutaneous T cell lymphomas (CTCL) are a heterogenous group of non-Hodgkin lymphomas derived from skin-homing T cells. These include mycosis fungoides and its leukemic variant Sezary syndrome, as well as the CD30+ lymphoproliferative disorders.Areas CoveredIn this review, we provide a summary of the current literature on CTCL, with a focus on the immunopathogenesis and treatment of mycosis fungoides and Sezary syndrome.Expert OpinionRecent advances in immunology have provided new insights into the biology of malignant T cells. This in turn has led to the development of new therapies that modulate the immune system to facilitate tumor clearance or target specific aspects of tumor biology.
引用
收藏
页码:985 / 996
页数:12
相关论文
共 50 条
  • [41] Cutaneous T-cell lymphoma
    Weenig, RH
    Pittelkow, MR
    MAYO CLINIC PROCEEDINGS, 2003, 78 (08) : 1054 - 1055
  • [42] Cutaneous T-cell lymphoma
    Arora, Shalabh
    Gogia, Ajay
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 152 (07) : 48 - 49
  • [43] Cutaneous T-cell lymphoma
    Perez, A
    Whittaker, S
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2006, 67 (04): : 178 - 183
  • [44] Cutaneous T-cell Lymphoma
    Weiner, David M.
    Rook, Alain H.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (05) : 1087 - 1110
  • [45] Cutaneous T-cell lymphoma
    Kotz, EA
    Anderson, D
    Thierst, BH
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2003, 17 (02) : 131 - 137
  • [46] Treatment of cutaneous T-cell lymphoma: Focus on vorinostat
    Heymann, Warren R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (04) : 696 - 697
  • [47] Emerging drugs for the treatment of cutaneous T-cell lymphoma
    Cheng, Melissa
    Zain, Jasmine
    Rosen, Steven T.
    Querfeld, Christiane
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (01) : 45 - 54
  • [48] Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
    Pelcovits, Ari
    Ollila, Thomas A.
    Olszewski, Adam J.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 989 - 998
  • [49] Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma
    Zhang, Ping
    Zhang, Mingzhi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
    Prince, H. Miles
    Newland, Kate M.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (06): : 625 - 634